newsfilter
← Latest News
ACCESS Newswire·

Lexaria Announces Positive Final Results From Human Pilot Study #5

Company Further Examining the Pursuit of the World's First Oral Liraglutide ProductKELOWNA, BC / ACCESS Newswire / February 5, 2026 / Lexaria Bioscience Corp. , , a global